SH
Sinopharm Group Co. Ltd.
SHTDY · OTC
$9.55 +1.27% (+$0.12)
1M -8.88%
Market Cap ¥39.4B
P/E Ratio 5.66x
Div. Yield 5.41%
ROE 8.48%
Bulios Fair Price
$10.93
14.5% upside
Current Price
$9.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SHTDY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
100 /100
Cheap EV/EBITDA 4.24x
P/S 0.07x
P/B 0.47x
Growth
14 /100
Declining Rev. growth 0.44%
FCF growth 12.27%
Book val. growth 7.26%
Profitability
12 /100
Weak Net margin 1.24%
Op. margin 2.90%
FCF margin 2.24%
Quality
41 /100
Average ROE 8.48%
ROA 1.78%
Asset turnover 1.43x
Debt
55 /100
Moderate Current ratio 1.41x
Int. coverage 6.68x
Net debt/EBITDA 2.31x
Stability
91 /100
Stable Rev. volatility 6.56%
EPS volatility 14.59%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SHTDY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Wanyong Lian
Employees
94,910
Headquarters
Shanghai